Published in Cancer Epidemiol Biomarkers Prev on October 14, 2014
Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses' Health Studies. Breast Cancer Res Treat (2014) 0.76
Childhood Physical and Sexual Abuse History and Leukocyte Telomere Length among Women in Middle Adulthood. PLoS One (2015) 0.76
Antidepressant use and circulating prolactin levels. Cancer Causes Control (2016) 0.75
Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst (1995) 3.88
Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev (1995) 3.70
Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol (2008) 3.41
The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95
Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res (2006) 2.27
Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev (2006) 2.14
Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res (2004) 1.67
Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am J Pathol (1995) 1.51
Prolactin synthesis and secretion by human breast cancer cells. Cancer Res (1995) 1.49
Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res (1980) 1.46
Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients. Clin Endocrinol (Oxf) (2006) 1.44
Body shape throughout life and correlations with IGFs and GH. Endocr Relat Cancer (2007) 1.43
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer (2006) 1.40
A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab (1980) 1.39
Long-term effect of a first pregnancy on the secretion of prolactin. N Engl J Med (1987) 1.37
Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci U S A (1999) 1.35
A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Res (2013) 1.25
Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes Control (2003) 1.24
Adipocyte prolactin: regulation of release and putative functions. Diabetes Obes Metab (2007) 1.21
Structural variants of prolactin: occurrence and physiological significance. Endocr Rev (1995) 1.21
Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells. Cell Signal (2011) 1.21
Prolactin as a chemoattractant for human breast carcinoma. Endocrinology (1999) 1.20
Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth. Breast Cancer Res Treat (2003) 1.15
Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women. Int J Cancer (2007) 1.11
The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. Eur J Cancer Clin Oncol (1988) 1.05
Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology? J Cell Mol Med (2012) 0.97
The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. Eur J Cancer Clin Oncol (1987) 0.96
Glycosylation of human prolactin regulates hormone bioactivity and metabolic clearance. J Endocrinol Invest (1993) 0.91
A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort. BMC Med Genet (2007) 0.91
Prolactin as a local growth promoter in patients with breast cancer: GCRI experience. Eur J Surg Oncol (2000) 0.91
Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort. Ann Oncol (2014) 0.89
Energy balance, early life body size, and plasma prolactin levels in postmenopausal women. Cancer Causes Control (2008) 0.87
Plasma prolactin levels and breast cancer: relation to parity, weight and height, and age at first birth. Int J Cancer (1981) 0.87
Rat lymphoma cell bioassay for prolactin: observations on its use and comparison with radioimmunoassay. Life Sci (1982) 0.87
Prolactin in breast and prostate cancer: molecular and genetic perspectives. Discov Med (2011) 0.87
Elevated levels of prolactin in nulliparous women. Br J Cancer (1981) 0.86
Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL. Endocrinology (2003) 0.85
Glycosylated human prolactin: alterations in glycosylation pattern modify affinity for lactogen receptor and values in prolactin radioimmunoassay. J Clin Endocrinol Metab (1990) 0.83
Different forms of prolactin have opposing effects on the expression of cell cycle regulatory proteins in differentiated mammary epithelial cells. Oncol Res (2006) 0.82
Hormonal changes following hypophysectomy in humans. Obstet Gynecol (1977) 0.82
Circulating prolactin levels and risk of epithelial ovarian cancer. Cancer Causes Control (2013) 0.81
Hormones and growth factors in nipple aspirates from normal women and benign breast disease patients. Cancer Detect Prev (1992) 0.80
Elevated bioactive prolactin in women at risk for familial breast cancer. Eur J Cancer Clin Oncol (1985) 0.79
Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer. Br J Cancer (1992) 0.79
Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes beta-casein gene expression in the rat mammary gland. Cell Tissue Res (2002) 0.79
Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones. J Natl Cancer Inst (1987) 0.78
Differential prolactin response to oral metoclopramide in nulliparous versus parous women throughout the menstrual cycle. Fertil Steril (1991) 0.78
Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay. Horm Metab Res (1988) 0.77
[Comparison of biological activity of high molecular weight and low molecular weight forms of immunoreactive prolactin from human serum in cultured lymphoma NB2 cells]. Vopr Med Khim (1997) 0.77
Analysis of molecular heterogeneity of prolactin in human systemic lupus erythematosus. Lupus (2004) 0.76
Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status. Cancer Epidemiol Biomarkers Prev (2015) 0.77